These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 35104801)

  • 1. Cellular senescence and the skeleton: pathophysiology and therapeutic implications.
    Khosla S; Farr JN; Monroe DG
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular senescence in bone.
    Farr JN; Khosla S
    Bone; 2019 Apr; 121():121-133. PubMed ID: 30659978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cellular senescence prevents age-related bone loss in mice.
    Farr JN; Xu M; Weivoda MM; Monroe DG; Fraser DG; Onken JL; Negley BA; Sfeir JG; Ogrodnik MB; Hachfeld CM; LeBrasseur NK; Drake MT; Pignolo RJ; Pirtskhalava T; Tchkonia T; Oursler MJ; Kirkland JL; Khosla S
    Nat Med; 2017 Sep; 23(9):1072-1079. PubMed ID: 28825716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent Roles of Estrogen Deficiency and Cellular Senescence in the Pathogenesis of Osteoporosis: Evidence in Young Adult Mice and Older Humans.
    Farr JN; Rowsey JL; Eckhardt BA; Thicke BS; Fraser DG; Tchkonia T; Kirkland JL; Monroe DG; Khosla S
    J Bone Miner Res; 2019 Aug; 34(8):1407-1418. PubMed ID: 30913313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis.
    Khosla S; Farr JN; Kirkland JL
    J Clin Endocrinol Metab; 2018 Apr; 103(4):1282-1290. PubMed ID: 29425296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone-targeted delivery of senolytics to eliminate senescent cells increases bone formation in senile osteoporosis.
    Xing X; Tang Q; Zou J; Huang H; Yang J; Gao X; Xu X; Ma S; Li M; Liang C; Tan L; Liao L; Tian W
    Acta Biomater; 2023 Feb; 157():352-366. PubMed ID: 36470392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteocyte Cellular Senescence.
    Farr JN; Kaur J; Doolittle ML; Khosla S
    Curr Osteoporos Rep; 2020 Oct; 18(5):559-567. PubMed ID: 32794138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Senescence with Aging and Type 2 Diabetes.
    Farr JN
    Endocrinol Metab (Seoul); 2023 Jun; 38(3):295-301. PubMed ID: 37312256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cell Senescence for the Treatment of Age-Related Bone Loss.
    Pignolo RJ; Samsonraj RM; Law SF; Wang H; Chandra A
    Curr Osteoporos Rep; 2019 Apr; 17(2):70-85. PubMed ID: 30806947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.
    Chandra A; Rajawat J
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Senescent Cells in the Bone Microenvironment.
    Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
    J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Clinical Potential of Senolytic Drugs.
    Kirkland JL; Tchkonia T; Zhu Y; Niedernhofer LJ; Robbins PD
    J Am Geriatr Soc; 2017 Oct; 65(10):2297-2301. PubMed ID: 28869295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of senolytics in osteoporosis and other skeletal pathologies.
    Doolittle ML; Monroe DG; Farr JN; Khosla S
    Mech Ageing Dev; 2021 Oct; 199():111565. PubMed ID: 34499959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular senescence in skeletal disease: mechanisms and treatment.
    He X; Hu W; Zhang Y; Chen M; Ding Y; Yang H; He F; Gu Q; Shi Q
    Cell Mol Biol Lett; 2023 Oct; 28(1):88. PubMed ID: 37891477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs.
    Zhu Y; Tchkonia T; Pirtskhalava T; Gower AC; Ding H; Giorgadze N; Palmer AK; Ikeno Y; Hubbard GB; Lenburg M; O'Hara SP; LaRusso NF; Miller JD; Roos CM; Verzosa GC; LeBrasseur NK; Wren JD; Farr JN; Khosla S; Stout MB; McGowan SJ; Fuhrmann-Stroissnigg H; Gurkar AU; Zhao J; Colangelo D; Dorronsoro A; Ling YY; Barghouthy AS; Navarro DC; Sano T; Robbins PD; Niedernhofer LJ; Kirkland JL
    Aging Cell; 2015 Aug; 14(4):644-58. PubMed ID: 25754370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cellular senescence in ageing and endocrine disease.
    Khosla S; Farr JN; Tchkonia T; Kirkland JL
    Nat Rev Endocrinol; 2020 May; 16(5):263-275. PubMed ID: 32161396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Senescence of skeletal stem cells and their contribution to age-related bone loss.
    Wölfel EM; Fernandez-Guerra P; Nørgård MØ; Jeromdesella S; Kjær PK; Elkjær AS; Kassem M; Figeac F
    Mech Ageing Dev; 2024 Oct; 221():111976. PubMed ID: 39111640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Senolytics: Potential for Alleviating Diabetes and Its Complications.
    Palmer AK; Tchkonia T; Kirkland JL
    Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33705532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Adiposity in Models of Radiation- and Aging-Related Bone Loss Is Dependent on Cellular Senescence.
    Chandra A; Lagnado AB; Farr JN; Schleusner M; Monroe DG; Saul D; Passos JF; Khosla S; Pignolo RJ
    J Bone Miner Res; 2022 May; 37(5):997-1011. PubMed ID: 35247283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elimination of Senescent Osteocytes by Bone-Targeting Delivery of β-Galactose-Modified Maytansinoid Prevents Age-Related Bone Loss.
    He Y; Zhang L; Chen X; Liu B; Shao X; Fang D; Lin J; Liu N; Lou Y; Qin J; Jiang Q; Guo B
    Adv Healthc Mater; 2024 Mar; 13(8):e2302972. PubMed ID: 38063283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.